Toll Free: 1-888-928-9744

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015

Published: Apr, 2015 | Pages: 25 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015

Summary 

Global Markets Direct's, 'Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2015', provides an overview of the Cancer Therapeutics CRC Pty Ltd's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cancer Therapeutics CRC Pty Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Cancer Therapeutics CRC Pty Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Cancer Therapeutics CRC Pty Ltd's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Cancer Therapeutics CRC Pty Ltd's pipeline products

Reason To Buy 

- Evaluate Cancer Therapeutics CRC Pty Ltd's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Cancer Therapeutics CRC Pty Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Cancer Therapeutics CRC Pty Ltd's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Cancer Therapeutics CRC Pty Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cancer Therapeutics CRC Pty Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Cancer Therapeutics CRC Pty Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Cancer Therapeutics CRC Pty Ltd Snapshot 4 Cancer Therapeutics CRC Pty Ltd Overview 4 Key Information 4 Key Facts 4 Cancer Therapeutics CRC Pty Ltd - Research and Development Overview 5 Key Therapeutic Areas 5 Cancer Therapeutics CRC Pty Ltd - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Pipeline Products - Partnered Products 9 Partnered Products/Combination Treatment Modalities 10 Pipeline Products - Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 Cancer Therapeutics CRC Pty Ltd - Pipeline Products Glance 13 Cancer Therapeutics CRC Pty Ltd - Early Stage Pipeline Products 13 Discovery Products/Combination Treatment Modalities 13 Cancer Therapeutics CRC Pty Ltd - Drug Profiles 14 Small Molecule Inhibiting Mitosis for Solid Tumors 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Small Molecule to Inhibit USP7 for Cancer 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecules For Cancer 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecules to Inhibit MOZ for Acute Myelocytic Leukemia 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Small Molecules to Inhibit Ubiquitin E3 Ligase E6AP for Cancer 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Cancer Therapeutics CRC Pty Ltd - Pipeline Analysis 19 Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Target 19 Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Molecule Type 20 Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action 21 Cancer Therapeutics CRC Pty Ltd - Dormant Projects 22 Cancer Therapeutics CRC Pty Ltd - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 24 Disclaimer 25
List of Tables
Cancer Therapeutics CRC Pty Ltd, Key Information 4 Cancer Therapeutics CRC Pty Ltd, Key Facts 4 Cancer Therapeutics CRC Pty Ltd - Pipeline by Indication, 2015 6 Cancer Therapeutics CRC Pty Ltd - Pipeline by Stage of Development, 2015 7 Cancer Therapeutics CRC Pty Ltd - Monotherapy Products in Pipeline, 2015 8 Cancer Therapeutics CRC Pty Ltd - Partnered Products in Pipeline, 2015 9 Cancer Therapeutics CRC Pty Ltd - Partnered Products/ Combination Treatment Modalities, 2015 10 Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products in Pipeline, 2015 11 Cancer Therapeutics CRC Pty Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2015 12 Cancer Therapeutics CRC Pty Ltd - Discovery, 2015 13 Cancer Therapeutics CRC Pty Ltd - Pipeline by Target, 2015 19 Cancer Therapeutics CRC Pty Ltd - Pipeline by Molecule Type, 2015 20 Cancer Therapeutics CRC Pty Ltd - Pipeline Products by Mechanism of Action, 2015 21 Cancer Therapeutics CRC Pty Ltd - Dormant Developmental Projects,2015 22



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify